SL
Methodology breakdown computing — it will appear here on its own.
Simulations Plus Inc. (SLP) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-07-11). See the full ratio breakdown and business-activity screen below for the reasoning.
Computing the full ratio and business-activity breakdown for SLP — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 62.30 | NEUTRAL |
| Stochastic %K (14) | 55.56 | NEUTRAL |
| CCI (20) | 76.40 | NEUTRAL |
| Williams %R (14) | -44.44 | NEUTRAL |
| MACD (12,26,9) | -0.01 | SELL |
| ROC (10) | 0.05 | BUY |
| Momentum (10) | 0.01 | BUY |
| EMA (10) | 18.41 | BUY |
| SMA (10) | 18.42 | BUY |
| EMA (20) | 18.39 | BUY |
| SMA (20) | 18.39 | BUY |
| EMA (30) | 18.33 | BUY |
| SMA (30) | 18.37 | BUY |
| EMA (50) | 18.07 | BUY |
| SMA (50) | 18.34 | BUY |
| EMA (100) | 17.32 | BUY |
| SMA (100) | 17.12 | BUY |
| EMA (200) | 16.84 | BUY |
| SMA (200) | 16.37 | BUY |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Health Information Services
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, OBESITYsym, and Thales products. In addition, the company offers Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, it provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, the company offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Research Triangle Park, North Carolina.
Background via Yahoo Finance — informational, not part of the verdict.
🔴 AVOID
The main driver: insider selling on the open market, analyst consensus is bearish. Too many signals pointing the wrong way. Wait for the picture to improve before committing capital.
Scores: 0 bullish / 3 bearish
Weak — low conviction, small size or skip
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BULLISH | 62 |
| ⏰ 4H | NEUTRAL | 30 |
| 🕐 1H | RANGING | 98 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | RANGING | 234 |
Peer movement computing — it will appear here on its own.
CLUSTER SELL 0 buys · 5 sells
Recent: WOLTOSZ WALTER S sold 3202131 sh @ $18.44 (2026-07-01); DiBella John Anthony II sold 86140 sh @ $18.36 (2026-07-06); DiBella John Anthony II sold 85140 sh @ $18.28 (2026-08-03)
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.
